Tivic health accelerates vns commercial strategy development

San francisco--(business wire)--tivic health® systems, inc. (“tivic health”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, today announced it has partnered with fletcher spaght (“fsi”), a leading healthcare growth strategy firm, to accelerate development of its commercial strategy for non-invasive cervical vagus nerve stimulation (“ncvns”). polaris market research estimates the global vagus nerve stimulation market will grow from $8.59 billion in.
TIVC Ratings Summary
TIVC Quant Ranking